Free Trial

Pacira BioSciences (PCRX) Insider Trading & Ownership

Pacira BioSciences logo
$16.73 +0.09 (+0.54%)
(As of 11/19/2024 ET)

Pacira BioSciences (NASDAQ:PCRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.40%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$136,240.40
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$3.41 M
Get PCRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pacira BioSciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PCRX Insider Buying and Selling by Quarter

Pacira BioSciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2024Daryl GauglerCOOSell500$12.86$6,430.00  
8/16/2024Marcelo BigalDirectorBuy1,512$13.25$20,034.00  
8/12/2024Frank D LeeCEOBuy8,264$12.10$99,994.40  
8/12/2024Mark FroimsonDirectorBuy1,400$11.58$16,212.00  
8/2/2024Jonathan SloninInsiderSell945$20.05$18,947.25  
7/2/2024Jonathan SloninInsiderSell2,836$28.25$80,117.00  
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
6/13/2024Daryl GauglerCOOSell1,000$28.38$28,380.00  
6/13/2024Kristen WilliamsInsiderSell7,452$28.38$211,487.76  
6/13/2024Paul J HastingsDirectorSell880$28.38$24,974.40  
6/12/2024Lauren RikerSVPSell3,970$28.72$114,018.40  
6/11/2024Jonathan SloninInsiderSell5,012$28.57$143,192.84  
3/8/2024Gary W PaceDirectorSell90,000$30.60$2,754,000.00  
3/6/2024Gary W PaceDirectorSell1,066$29.67$31,628.22  
(Data available from 1/1/2013 forward)

PCRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Pacira BioSciences includes Anthony Molloy, Charles A Reinhart III, Charles Anthony Laranjeira, Daryl Gaugler, David M Stack, Frank D Lee, Gary W Pace, John P Phd Longenecker, Jonathan Slonin, Kristen Marie Williams, Kristen Williams, Lauren Bullaro Riker, Lauren Riker, Marcelo Bigal, Mark A Kronenfeld, Mark Froimson, Max Reinhardt, Paul J Hastings, and Roy Winston. Learn more on insiders at PCRX.

6.40% of Pacira BioSciences stock is owned by insiders. Learn more on PCRX's insider holdings.

The following insiders have purchased PCRX shares in the last 24 months: Frank D Lee ($99,994.40), Marcelo Bigal ($20,034.00), and Mark Froimson ($16,212.00).

Insiders have purchased a total of 11,176 PCRX shares in the last 24 months for a total of $136,240.40 bought.

The following insiders have sold PCRX shares in the last 24 months: Anthony Molloy ($20,917.26), Charles A Reinhart III ($48,191.64), Daryl Gaugler ($210,899.89), David M Stack ($197,211.42), Gary W Pace ($2,995,154.92), Jonathan Slonin ($242,257.09), Kristen Marie Williams ($239,473.01), Kristen Williams ($211,487.76), Lauren Bullaro Riker ($292,643.94), Lauren Riker ($114,018.40), Mark A Kronenfeld ($555,600.00), Paul J Hastings ($47,211.60), and Roy Winston ($87,117.13).

Insiders have sold a total of 161,998 Pacira BioSciences shares in the last 24 months for a total of $5,262,184.06 sold.

Pacira BioSciences Key Executives



This page (NASDAQ:PCRX) was last updated on 11/20/2024 by MarketBeat.com Staff
From Our Partners